Status:
COMPLETED
Vaginal Progesterone Against a Second Attack of Antepartum Haemorrhage in Placenta Previa Women
Lead Sponsor:
Nourhan Ashraf ElSherbiny
Conditions:
Placenta Previa
Eligibility:
FEMALE
24-34 years
Brief Summary
Placenta praevia is associated with an increased risk of preterm delivery (PTD) especially if associated with bleeding and uterine contractions . In this study we will determine the effect of Progest...
Detailed Description
Placenta previa is a problem of pregnancy in which the placenta grows in the lowest part of the womb (uterus) and covers all or part of the opening to the cervix . The prevalence of placenta previa h...
Eligibility Criteria
Inclusion
- o Women diagnosed as placenta previa.
- Women aged 20-40 years, who were pregnant in a single foetus
- Gestational age ranging between 24 and 34 weeks
- Patient had attack of Antepartum Haemorrhage or history of Antepartum Haemorrhage
Exclusion
- o History of previous PTD
- Polyhydramnios
- Severe attack of bleeding requiring an immediate intervention
- Intrauterine foetal death
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04725929
Start Date
January 1 2021
End Date
July 1 2021
Last Update
June 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Maternity Hospital
Cairo, Egypt, 11865